Editors' Pick Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis. Bergvall N, Lahoz R, Reynolds T, Korn JR Curr Med Res Opin. 2014 May 2. PMID: 24754349. Abstract CommentRecommendBookmarkWatch
